GÜVEN, D. C. Et Al. 2022. The use of fulvestrant before chemotherapy improves survival in hormone-positive breast cancer: a real-life study. Turkish Journal of Medical Sciences , vol.52, no.5 , 1551-1558.

GÜVEN, D. C., Yildirim, H. Ç., Erul, E., Şahin, T. K., Çakir, İ. Y., AKTEPE, O. H., ... KERTMEN, N.(2022). The use of fulvestrant before chemotherapy improves survival in hormone-positive breast cancer: a real-life study. Turkish Journal of Medical Sciences , vol.52, no.5, 1551-1558.

GÜVEN, DENİZ Et Al. "The use of fulvestrant before chemotherapy improves survival in hormone-positive breast cancer: a real-life study," Turkish Journal of Medical Sciences , vol.52, no.5, 1551-1558, 2022

GÜVEN, DENİZ C. Et Al. "The use of fulvestrant before chemotherapy improves survival in hormone-positive breast cancer: a real-life study." Turkish Journal of Medical Sciences , vol.52, no.5, pp.1551-1558, 2022

GÜVEN, D. C. Et Al. (2022) . "The use of fulvestrant before chemotherapy improves survival in hormone-positive breast cancer: a real-life study." Turkish Journal of Medical Sciences , vol.52, no.5, pp.1551-1558.

@article{article, author={DENİZ CAN GÜVEN Et Al. }, title={The use of fulvestrant before chemotherapy improves survival in hormone-positive breast cancer: a real-life study}, journal={Turkish Journal of Medical Sciences}, year=2022, pages={1551-1558} }